Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System-Reference-Cited by-同舟云学术

Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System

Published:2019-09-18 Issue:43 Volume:11 Page:39633-39647
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Kuplennik Nataliya¹,Lang Kristina²,Steinfeld Robert²,Sosnik Alejandro¹^ORCID

Affiliation:

1. Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering, Technion-Israel Institute of Technology, 3200003 Haifa, Israel

2. Clinic for Neurology, University Children Hospital Zurich, 8032 Zurich, Switzerland

Funder

Nieders?chsische Ministerium f?r Wissenschaft und Kultur

Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.9b14659

Reference58 articles.

1. Two decades of new drug development for central nervous system disorders

2. Blood-brain barrier at the interface of air pollution-associated neurotoxicity and neuroinflammation

3. The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction

4. Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases

5. The role of the blood–CNS barrier in CNS disorders and their treatment

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on the Strategies for Crossing the Blood–Brain Barrier;Molecular Pharmaceutics;2024-09-04

2. Nanoparticle delivery for central nervous system diseases and its clinical application;Nano Research;2024-04-03

3. Folic acid: friend or foe in cancer therapy;Journal of International Medical Research;2024-01

4. Etoposide-Loaded Colloidal Delivery Systems Based on Biodegradable Polymeric Carriers;Colloid Journal;2023-10

5. New advances in diagnosis and treatment of nano drug delivery systems across the blood-brain barrier;Nanocomposites;2023-09-20